ΕΠΙΜΕΝΟΥΣΑ ΚΟΙΛΙΑΚΗ ΤΑΧΥΚΑΡΔΙΑ - ΦΑΡΜΑΚΕΥΤΙΚΗ ΘΕΡΑΠΕΙΑ
Περίληψη
No AbstractΑναφορές
Τούτουζας Π, Μπουντούλας Χ. Καρδιακές Παθήσεις Εκδόσεις Παρισιάνος 1992.
Di Bianco R.: Chronic Ventricular Arrhythmias: Which Drug for Which patient? Am J Cardiol 1988; 61:83Α- 94Α.
Giardina EG, Wechsler ΜΕ.: Low dose - quinidine - mexiletine combination therapy versus quinidine monotherapy for Treatment of ventricular arrhythmias. J Am Coll Cardiol 1990; 15: 1138-45.
Zipes DP.: Symposium on new aspects of antiarrhythmic therapy. Introduction: miles to go. Am J Cardiol 1978; 41: 975-978.
Minardo JD, Heget JJ, Miles WM, Zipes DP.: Clinical characteristics of patients with verticular fibrilation during antiarrhythmic drug therapy. Ν Engl J Med 1988; 319: 257-62.
Henning R, Grenvik Α.: Critical care cardiology Ed Churchill Livingstone 1989.
Goldberger Ε. Cardiac Emergencies 4th ED C.V. Mosby 1985.
Luccheai BR. Rationale of therapy in the patient with acute myocardial infarction and life - threatening arrhythmias - a focus on bretylium Am J Cardiol 1984; 54: 14Α.
Kerin NZ, Aragon Ε, Marinescum G, Faitel Κ. Mexiletine Long-term efficacy and side effects in patients with chronic drug - resistant potentially lethal venticular arrhythmias, Archintmed 1990; 150: 381-84.
Manolis AS, Deering TF, Cameron J, Estes ΝΑ. Mexiletine: pharmacology and therapy use. Clin Cardiol 1990; 13: 349-59.
Manz Μ, Luderitz Β. Emergency therapy of venticular tachycardias: Lidocaine versus ajmaline. Dtsch Med Wochenschr 1988; 113: 1317-21.
Mletzko R, Jyng W, Mant Μ, Luderitz Β . Heart - minute volune during persistent ventricular tachycardia: anti-arrhythmia intervention using ajmaline. Ζ Kardial 1991; 80: 459-62.
Γιαλάφος, Κουλιζάκης Ν, Κάνδυλας Ι, Τούτουζας Π. Θεραπευτική αντιμετώπιση των επειγουσών ταχυαρρυθμιών. Καρδιολογικά θέματα, διαλέξεις Ιπποκρατείου 1992.
Baedeker W, Goedel - Meinent, Hofman Μ. Long - term treatment with amiodarone. Ζ Kardiol 1991; 80: 158-66.
Schutzenberger W, Leisch F, Kerschner Κ. Clinical efficacy of intravenous amiodarone in the short term treatment of recurrent sustained ventricular tachycardia and Ventricular fibrilation. Br Heart J 1989; 62: 367-71.
Nalos PC, Ismail Υ, Pappas JM, Nuitray W. Intravenous amiodarone for short-term treatment of refractory ventricular tachycardia or fibrillation. Am Heart J 1991; 122: 1629-32.
Ochi RP, Goldenberg IF, Almquist Α, Pritzker Μ. Intravenous aniodarone for the rapid treatment of life-thretening ventricular arrhythmias in critically ill patients with coronary antery disease, Am J Cardiol 1989; 64: 599-603.
Κim Sg, Mannino MM, Chon R, Roth JA. rapid suppression of spontaneous ventricular arrhythmias during oral amiodarone loading. Ann Intern Med 1992; 117: 197-201.
Sherwood LM, Parris EE. Preventable drug reactions - causes and cures. Ν Engl J Med 1971; 284: 1361-68.
Greenspan AM, Spielman SR, Horowitz LN. Combination antiarrhythmic drug therapy for ventricular tachyarrhythmias. PACE Pacing V Clin Electrophysiol 1986; 9: 565-76.
Nitsch J. Combined drug treatment of tachyarrhythmias. Studio Ζ. Corp Com Verlags Gmbh 1992.
Κim SG. Values and limitations of programmed stimulation and ambulatory monitoring in the management of ventricular tachycardia. Am J Cardiol 1988; 62-7.
Katritsis D, Camm Α. Are antiarrhythmic drugs safe? Clin Cardiol 1990; 13: 491-6.
Duff HJ, Roden D, Drimmk, Oates JA, Woosley RL. Mexiletine in the treatment of resistant ventricular arrhythmias enhancement of efficacy and reduction of dose-related side effects by combination with quinidine. Circulation 1983; 67: 1124.
Witford EG, McGovern Β, Schoenfeld ΜΗ. Long-term efficacy of Mexiletine alone and in combination with class IA antiarrhythmic drugs for refractory Ventricular arrhythmias. Am Heart J 1988; 115: 360.
Zacia F, Ghihellim, Bombardini Τ, De Collibus C. Mexiletine in patients with progressive infraction and reduced ventricular Function: anti arrhythmic efficacy and Hemodynamic effects. G Ital Cardiol 1990; 20: 569-75.
James ΜΑ, Papouchado Ρ, Jones JV. Combined anti-arrhythmic therapy with class Ι and class 3 drugs. Postgrad Med J 1989; 65: 519-24.
Wagner F, Kalusche D, Trenk D. Drug interaction between propafenone and metoprolol. Br J Clin Pharm 1987; 24: 213.
Hirsowitz, Podrid PJ, Lambents, Stein J, Lown Β. The role of beta-blocking agents as adjunct therapy to membrane stabilizing agents in malignant ventricular arrhythmia. Am Heart J 1986; 111: 825.
Tonet J, Frank R, Fontaine G, Grosgogeat Υ. Efficacy of the combination of low doses of beta-blocker and amiodarone in the treatment of refractory ventricular Tachycardia Arch Mal Coenr Vaissl 1989; 82: 1511-7.
